Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Keratoconus | 23 | 2023 | 76 | 8.140 |
Why?
|
| Contact Lenses | 12 | 2023 | 71 | 5.350 |
Why?
|
| Visual Acuity | 35 | 2025 | 179 | 4.400 |
Why?
|
| Corneal Wavefront Aberration | 11 | 2021 | 35 | 4.090 |
Why?
|
| Sclera | 11 | 2021 | 57 | 3.900 |
Why?
|
| Refraction, Ocular | 20 | 2025 | 127 | 3.230 |
Why?
|
| Refractive Errors | 17 | 2025 | 58 | 2.960 |
Why?
|
| Down Syndrome | 10 | 2025 | 16 | 2.480 |
Why?
|
| Vision Tests | 13 | 2025 | 50 | 1.870 |
Why?
|
| Corneal Topography | 12 | 2020 | 37 | 1.620 |
Why?
|
| Adult | 37 | 2025 | 1683 | 1.550 |
Why?
|
| Humans | 51 | 2025 | 5477 | 1.490 |
Why?
|
| Cornea | 10 | 2021 | 140 | 1.350 |
Why?
|
| Contrast Sensitivity | 7 | 2022 | 64 | 1.260 |
Why?
|
| Contact Lenses, Hydrophilic | 7 | 2021 | 78 | 1.030 |
Why?
|
| Lens, Crystalline | 3 | 2023 | 34 | 0.890 |
Why?
|
| Vision Disorders | 2 | 2020 | 44 | 0.880 |
Why?
|
| Male | 20 | 2025 | 2765 | 0.870 |
Why?
|
| Optics and Photonics | 2 | 2020 | 21 | 0.830 |
Why?
|
| Eyeglasses | 6 | 2025 | 30 | 0.830 |
Why?
|
| Female | 20 | 2025 | 2811 | 0.800 |
Why?
|
| Benchmarking | 1 | 2022 | 13 | 0.730 |
Why?
|
| Middle Aged | 19 | 2025 | 1098 | 0.670 |
Why?
|
| Contact Lens Solutions | 1 | 2020 | 8 | 0.670 |
Why?
|
| Young Adult | 12 | 2025 | 850 | 0.660 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2020 | 11 | 0.630 |
Why?
|
| Astigmatism | 8 | 2021 | 35 | 0.630 |
Why?
|
| Polyethylene Glycols | 1 | 2020 | 28 | 0.630 |
Why?
|
| Habituation, Psychophysiologic | 1 | 2019 | 5 | 0.610 |
Why?
|
| Myopia | 5 | 2023 | 114 | 0.510 |
Why?
|
| Prosthesis Fitting | 4 | 2020 | 23 | 0.490 |
Why?
|
| Pupil | 6 | 2023 | 45 | 0.430 |
Why?
|
| Prescriptions | 2 | 2023 | 19 | 0.370 |
Why?
|
| Adolescent | 7 | 2025 | 806 | 0.360 |
Why?
|
| Models, Biological | 3 | 2009 | 131 | 0.350 |
Why?
|
| Physical Examination | 2 | 2020 | 7 | 0.320 |
Why?
|
| Vision, Ocular | 3 | 2020 | 33 | 0.290 |
Why?
|
| Monitoring, Physiologic | 2 | 2018 | 14 | 0.280 |
Why?
|
| Child | 4 | 2019 | 657 | 0.270 |
Why?
|
| Reproducibility of Results | 5 | 2021 | 350 | 0.260 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2006 | 3 | 0.250 |
Why?
|
| Retina | 5 | 2013 | 130 | 0.240 |
Why?
|
| Algorithms | 3 | 2019 | 276 | 0.210 |
Why?
|
| Equipment Design | 4 | 2018 | 73 | 0.190 |
Why?
|
| Aberrometry | 2 | 2020 | 8 | 0.190 |
Why?
|
| Research Design | 1 | 2021 | 35 | 0.180 |
Why?
|
| Eye | 1 | 2021 | 20 | 0.180 |
Why?
|
| Temperature | 2 | 2018 | 63 | 0.180 |
Why?
|
| Emmetropia | 1 | 2020 | 14 | 0.160 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2019 | 3 | 0.160 |
Why?
|
| Treatment Outcome | 2 | 2013 | 212 | 0.150 |
Why?
|
| Dilatation, Pathologic | 1 | 2019 | 5 | 0.150 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 31 | 0.150 |
Why?
|
| Prosthesis Failure | 1 | 2018 | 5 | 0.150 |
Why?
|
| Cold Climate | 1 | 2018 | 1 | 0.150 |
Why?
|
| Thermometry | 1 | 2018 | 1 | 0.150 |
Why?
|
| Tears | 1 | 2018 | 21 | 0.140 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 3 | 2007 | 20 | 0.140 |
Why?
|
| Aging | 2 | 2009 | 127 | 0.130 |
Why?
|
| Conjunctival Diseases | 1 | 2015 | 4 | 0.120 |
Why?
|
| Eyelid Diseases | 1 | 2015 | 5 | 0.120 |
Why?
|
| Hypoxia | 1 | 2015 | 12 | 0.120 |
Why?
|
| Corneal Diseases | 1 | 2015 | 10 | 0.120 |
Why?
|
| Aged, 80 and over | 4 | 2008 | 320 | 0.110 |
Why?
|
| Pattern Recognition, Visual | 1 | 2013 | 34 | 0.100 |
Why?
|
| Prosthesis Design | 1 | 2013 | 27 | 0.100 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 97 | 0.100 |
Why?
|
| Computer Simulation | 3 | 2008 | 188 | 0.090 |
Why?
|
| Visual Perception | 2 | 2013 | 61 | 0.080 |
Why?
|
| Preoperative Care | 1 | 2009 | 7 | 0.080 |
Why?
|
| Vision, Monocular | 1 | 2007 | 16 | 0.070 |
Why?
|
| Eye Movements | 1 | 2008 | 47 | 0.070 |
Why?
|
| Iris | 1 | 2007 | 10 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2017 | 132 | 0.060 |
Why?
|
| Refractometry | 1 | 2006 | 5 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2007 | 73 | 0.060 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2007 | 62 | 0.060 |
Why?
|
| Aged | 4 | 2018 | 859 | 0.060 |
Why?
|
| Cataract | 1 | 2004 | 4 | 0.060 |
Why?
|
| Light | 1 | 2004 | 43 | 0.050 |
Why?
|
| Models, Statistical | 1 | 2004 | 70 | 0.050 |
Why?
|
| Accommodation, Ocular | 1 | 2004 | 36 | 0.050 |
Why?
|
| Keratoplasty, Penetrating | 1 | 2021 | 4 | 0.040 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 277 | 0.040 |
Why?
|
| Reading | 1 | 2020 | 77 | 0.040 |
Why?
|
| Fluorophotometry | 1 | 2018 | 3 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2018 | 119 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2017 | 19 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2017 | 34 | 0.030 |
Why?
|
| Tomography, Optical Coherence | 1 | 2018 | 217 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2004 | 131 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2004 | 284 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2009 | 17 | 0.020 |
Why?
|
| Disease Progression | 1 | 2009 | 74 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2009 | 148 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2008 | 148 | 0.020 |
Why?
|
| Rotation | 1 | 2007 | 15 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2008 | 115 | 0.020 |
Why?
|
| Reference Values | 1 | 2006 | 28 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 136 | 0.020 |
Why?
|
| Prognosis | 1 | 2006 | 59 | 0.020 |
Why?
|
| Scattering, Radiation | 1 | 2004 | 18 | 0.010 |
Why?
|
| Linear Models | 1 | 2004 | 60 | 0.010 |
Why?
|
| Mydriatics | 1 | 2004 | 11 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2004 | 96 | 0.010 |
Why?
|
| Mathematics | 1 | 2003 | 27 | 0.010 |
Why?
|